Literature DB >> 3511578

The role of major and minor histocompatibility antigens in active enhancement of rat kidney allograft survival by blood transfusion.

I V Hutchinson, P J Morris.   

Abstract

Rats given a blood transfusion do not reject a subsequent kidney allograft from the same donor strain. This effect is strain-specific so that pretransplant blood transfusion from a LEW (RT1l) rat will protect a LEW kidney in a DA (RT1a) recipient but not a PVG/c (RT1c) kidney. The same is true in other combinations. Using DA or PVG.RT1a congenic recipients we have shown that sharing of all or part of the MHC or of minor alloantigens by the blood transfusion and kidney transplant donors is sufficient to prolong allograft survival. Activation of suppression against minor alloantigens appears to require two signals: one is the minor alloantigen and the other may be a major histocompatibility complex alloantigen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3511578     DOI: 10.1097/00007890-198602000-00006

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation.

Authors:  S Fujisaki; N Murase; A J Demetris; M Tanabe; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

2.  Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.

Authors:  R L Quigley; K J Wood; P J Morris
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

Review 3.  Advances in transplantation immunology.

Authors:  P J Morris
Journal:  Jpn J Surg       Date:  1987-09

4.  Human allograft acceptance is associated with immune regulation.

Authors:  A M VanBuskirk; W J Burlingham; E Jankowska-Gan; T Chin; S Kusaka; F Geissler; R P Pelletier; C G Orosz
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.